🔎 Trials Near Me

Gara Jalqabaatti › Myelodysplastic Syndromes › Illinois › Chicago

Qorannoo klinikaalii Myelodysplastic Syndromes Chicago, IL keessatti

Qorannoo 13 Myelodysplastic Syndromes f Chicago fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Northwestern University, Chicago
  • Swedish Covenant Hospital, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06577441

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Namoota walitti qabaa jiraSadarkaa 1
  • University of Chicago Comprehensive Cancer Center, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06484062

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Northwestern University, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
  • fi 1 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05564390

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

Namoota walitti qabaa jiraSadarkaa 3
  • University of Chicago, Duchossois Center for Advanced Medicine (DCAM), Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06465953

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Namoota walitti qabaa jiraSadarkaa 1/2
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Hanga umuriin 22 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04726241

Mosaic Trial for Stem Cell Transplant Recipients

Namoota walitti qabaa jira
  • Northwestern University Feinberg School of Medicine, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06960993

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

Namoota walitti qabaa jiraSadarkaa 1/2
  • Northwestern University, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT05732103

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Northwestern, Chicago
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 24-Bit-2026 · NCT04988555

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Umuriin 1 hanga 40 · Saalaa hunda · Haaromfame 12-Bit-2026 · NCT05292664

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

Namoota walitti qabaa jira
  • University of Chicago Comprehensive Cancer Center, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Gur-2026 · NCT05745285

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Chicago
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Namoota walitti qabaa jiraSadarkaa 1
  • Northwestern Medicine - Northwestern Memorial Hospital Galter Pavilion, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2025 · NCT06501196

Qorannoo Myelodysplastic Syndromes magaalota biroo keessatti

Qorannoo biroo Chicago keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.